Comerica Bank’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $881K | Sell |
26,158
-7,328
| -22% | -$236K | 0.01% | 1515 |
|
|
2022
Q3 | $1.07M | Sell |
33,486
-3,722
| -10% | -$121K | 0.01% | 1430 |
|
|
2022
Q2 | $1.21M | Sell |
37,208
-175
| -0.5% | -$4.73K | 0.01% | 1419 |
|
|
2022
Q1 | $1.03M | Sell |
37,383
-225
| -0.6% | -$5.35K | 0.01% | 1570 |
|
|
2021
Q4 | $768K | Sell |
37,608
-1,755
| -4% | -$33.7K | 0.01% | 1697 |
|
|
2021
Q3 | $732K | Sell |
39,363
-1,113
| -3% | -$22.2K | ﹤0.01% | 1813 |
|
|
2021
Q2 | $768K | Sell |
40,476
-3,090
| -7% | -$65.5K | ﹤0.01% | 1850 |
|
|
2021
Q1 | $957K | Sell |
43,566
-1,519
| -3% | -$36.1K | 0.01% | 1767 |
|
|
2020
Q4 | $1.04M | Buy |
45,085
+100
| +0.2% | +$1.87K | 0.01% | 1700 |
|
|
2020
Q3 | $825K | Sell |
44,985
-130
| -0.3% | -$2.53K | 0.01% | 1670 |
|
|
2020
Q2 | $1.1M | Buy |
45,115
+3,737
| +9% | +$54.2K | 0.01% | 1442 |
|
|
2020
Q1 | $442K | Buy |
41,378
+1,619
| +4% | +$13.6K | ﹤0.01% | 1780 |
|
|
2019
Q4 | $402K | Sell |
39,759
-232
| -0.6% | -$2.18K | ﹤0.01% | 1971 |
|
|
2019
Q3 | $395K | Buy |
39,991
+823
| +2% | +$8.67K | ﹤0.01% | 1965 |
|
|
2019
Q2 | $451K | Sell |
39,168
-3,252
| -8% | -$39.2K | ﹤0.01% | 1929 |
|
|
2019
Q1 | $562K | Buy |
42,420
+937
| +2% | +$15.6K | ﹤0.01% | 1839 |
|
|
2018
Q4 | $667K | Buy |
41,483
+359
| +0.9% | +$6.12K | 0.01% | 1751 |
|
|
2018
Q3 | $645K | Sell |
41,124
-3,568
| -8% | -$55.3K | 0.01% | 1791 |
|
|
2018
Q2 | $706K | Buy |
44,692
+552
| +1% | +$8.23K | ﹤0.01% | 1810 |
|
|
2018
Q1 | $651K | Buy |
44,140
+790
| +2% | +$11.7K | ﹤0.01% | 1812 |
|
|
2017
Q4 | $642K | Sell |
43,350
-1,189
| -3% | -$17.4K | ﹤0.01% | 1829 |
|
|
2017
Q3 | $655K | Buy |
44,539
+318
| +0.7% | +$4.54K | ﹤0.01% | 1804 |
|
|
2017
Q2 | $674K | Sell |
44,221
-2,351
| -5% | -$33.9K | 0.01% | 1735 |
|
|
2017
Q1 | $699K | Buy |
46,572
+1,754
| +4% | +$24.5K | 0.01% | 1755 |
|
|
2016
Q4 | $766K | Buy |
44,818
+2,418
| +6% | +$42.5K | 0.01% | 1705 |
|
|
2016
Q3 | $809K | Buy |
42,400
+381
| +0.9% | +$7.46K | 0.01% | 1610 |
|
|
2016
Q2 | $820K | Sell |
42,019
-642
| -2% | -$12.6K | 0.01% | 1605 |
|
|
2016
Q1 | $882K | Buy |
42,661
+291
| +0.7% | +$5.73K | 0.01% | 1536 |
|
|
2015
Q4 | $792K | Sell |
42,370
-229
| -0.5% | -$4.39K | 0.01% | 1530 |
|
|
2015
Q3 | $728K | Sell |
42,599
-41,315
| -49% | -$755K | 0.01% | 1577 |
|
|
2015
Q2 | $1.56M | Buy |
83,914
+42,691
| +104% | +$792K | 0.01% | 1606 |
|
|
2015
Q1 | $787K | Sell |
41,223
-39,999
| -49% | -$740K | 0.01% | 1598 |
|
|
2014
Q4 | $1.34M | Buy |
81,222
+39,604
| +95% | +$679K | 0.01% | 1643 |
|
|
2014
Q3 | $736K | Buy |
41,618
+553
| +1% | +$10.9K | 0.01% | 1613 |
|
|
2014
Q2 | $848K | Sell |
41,065
-1,310
| -3% | -$26.9K | 0.01% | 1583 |
|
|
2014
Q1 | $923K | Sell |
42,375
-1,557
| -4% | -$35.7K | 0.01% | 1602 |
|
|
2013
Q4 | $1.17M | Sell |
43,932
-4,273
| -9% | -$105K | 0.01% | 1465 |
|
|
2013
Q3 | $1.14M | Buy |
48,205
+2,010
| +4% | +$46.9K | 0.01% | 1557 |
|
|
2013
Q2 | $994K | Buy |
+46,195
| New | +$996K | 0.01% | 1393 |
|
Other funds holding VIVO
MF
NAM
Comerica Bank's VIVO Position: Q4 2022 in Review
Comerica Bank reduced its Meridian Bioscience Inc (VIVO) stake by 22% in Q4 2022, selling an estimated $236K and leaving 26,158 shares worth $881K. The position accounts for 0.01% of the portfolio, ranked #1515.
Comerica Bank first reported a position in VIVO in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.56M in Q2 2015. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.
- Comerica Bank held 26,158 shares of Meridian Bioscience Inc worth $881K as of Q4 2022.
- Comerica Bank sold 7,328 Meridian Bioscience Inc shares in Q4 2022, an estimated $236K.
- Meridian Bioscience Inc made up 0.01% of Comerica Bank's portfolio in Q4 2022, its #1515 holding.
- Comerica Bank first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 39 quarters since.
- Comerica Bank's Meridian Bioscience Inc position peaked at $1.56M in Q2 2015.
- 218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.
Based on Comerica Bank's 13F filing for Q4 2022, filed 26 Jan 2023.